Pharmaceutical regulatory landscape world wide

 we are providing below a list of the internationally recognized bodies that are proving regulatory-related advice to industry and government as well.  

First, we should understand the regulatory model of the global market. 

There are mainly two types of markets established and emerging, further, we will discuss each.

1.       Established – These markets are the US, EU, Japan, Canada Australia, and now China from 2017. The main basis is ICH. The countries that are full-time members of ICH are considered as an Established regulatory market.

2.       Emerging – This market rest of the world is considered emerging, some of the regulatory bodies/agency is an observers of ICH and are also part of the emerging regulatory market.

Apart from the above regulatory bodies some of the international agencies, associations, Research institutions, organizations, centers, offices, and the non-government agency also plays a major role in the development of pharmaceutical policies and strategy.